Myeloperoxidase in chronic kidney disease

Indian Journal of Clinical Biochemistry

Volumn 26, Issue 1, 2011, Pages 28-31

  Madhusudhana Rao, A ^a   Anand, Usha ^a   Anand, C V ^a  

^a PSG INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

Cardiovascular disease; Chronic kidney disease; MPO hydrogen peroxide chloride system; Oxidative stress; Uraemic toxins

Indexed keywords

CREATININE; MYELOPEROXIDASE; UREMIC TOXIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; UREA BLOOD LEVEL;

EID: 79952249123     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12291-010-0075-1     Document Type: Article

References (18)

1. MB Hampton AJ Kettle CC Winterbourn 1998 Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing Blood 92 3007 3017 1:CAS:528:DyaK1cXntFCqs74%3D 9787133 (Pubitemid 28492304)
2. EA Podrez HM Abu-soud SL Hazen 2000 Myeloperoxidase generated oxidants and atherosclerosis Free Radic Biol Med 28 1717 1725 1:CAS:528: DC%2BD3cXls1Giu7Y%3D 10.1016/S0891-5849(00)00229-X 10946213 (Pubitemid 30628658)
3. KE Brown EM Brunt JW Heinecke 2001 Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver Am J Pathol 159 2081 2088 1:CAS:528:DC%2BD38Xhslarug%3D%3D 10.1016/S0002-9440(10) 63059-3 11733358 (Pubitemid 33104262)
4. CC Winterbourn AJ Kettle 2000 Biomarkers of myeloperoxidase derived hypo chlorous acid Free Radic Biol Med 29 403 409 1:CAS:528:DC%2BD3cXntVWgsLo%3D 10.1016/S0891-5849(00)00204-5 11020661
5. JW Heinecke 1999 Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders J Lab Clin Med 133 321 325 1:CAS:528:DyaK1MXivVygsLo%3D 10.1016/S0022-2143(99)90061-6 10218761 (Pubitemid 29373028)
6. JA Vita ML Brennan N Gokce SA Mann M Goormastic MH Shishehbor, et al. 2004 Serum myeloperoxidase levels independently predict endothelial dysfunction in humans Circulation 110 1134 1139 1:CAS:528:DC%2BD2cXmvV2gt7s%3D 10.1161/01.CIR.0000140262.20831.8F 15326065 (Pubitemid 39319014)
7. ML Brennan MS Penn FV Vn Lente V Nambi MH Shishehbor RJ Aviles 2003 Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 1595 1604 1:CAS:528:DC%2BD3sXosFWktbo%3D 10.1056/NEJMoa035003 14573731 (Pubitemid 37288567)
8. AS Levey J Coresh E Balk AT Kausz A Levin MW Steffes, et al. 2003 National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 137 147 12859163
9. Levey AS, Coresh J, Greene T et al. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol 2005;16:69A.
10. AJ Krueger JJ Yang TA Roy DJ Robbins CR Mackerer 1990 An automated myeloperoxidase assay Clin Chem 36 158 1:STN:280:DyaK3c7isFSltQ%3D%3D 2153483
11. BJ Arsenault ES Stroes SM Boekholdt 2009 Is myeloperoxidase a useful marker to predict the risk of cardiovascular events? Curr Cardiovasc Risk Rep 3 137 143 10.1007/s12170-009-0022-y
12. DE Weiner H Tighiourat MG Amin PC Stark B Macleod JL Griffith, et al. 2004 Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 1307 1315 10.1097/01.ASN.0000123691.46138.E2 15100371 (Pubitemid 38526012)
13. E Malle T Buch HJ Grone 2003 Myeloperoxidase in kidney disease Kidney Int 64 1956 1967 1:CAS:528:DC%2BD3sXpvFOru7s%3D 10.1046/j.1523-1755.2003.00336.x 14633118 (Pubitemid 37449530)
14. Y Maruyama B Lindholm P Stenvinkel 2004 Inflammation and oxidative stress in ESRD-the role of myeloperoxidase J Nephrol 17 Suppl 8 72 76
15. BC Capeillere V Gausson AT Nguyen LB Descamps T Drueke SV Witko 2006 Respective role of uraemic toxins and myeloperoxidase in the uraemic state Nephrol Dial Transplant 21 1555 1563 10.1093/ndt/gfl007 (Pubitemid 43840618)
16. A Slungaard JR Mahoney 1991 Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids J Biol Chem 266 4903 4910 1:CAS:528:DyaK3MXit1OgsL0%3D 2002037 (Pubitemid 21909440)
17. P Dirnhuber F Schutz 1948 The isomeric transformation of urea into ammonium cyanate in aqueous solutions Biochem J 42 628 632 1:CAS:528: DyaH1MXmsVQ%3D
18. Q Mingwei WE John PW Simon 1997 Cyanate-mediated inhibition of neutrophil myeloperoxidase activity Biochem J 326 159 166